PCI Biotech Holding ASA reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was NOK 14.69 million compared to NOK 18.15 million a year ago. Basic loss per share from continuing operations was NOK 0.39 compared to NOK 0.49 a year ago.
For the six months, net loss was NOK 37.7 million compared to NOK 41.92 million a year ago. Basic loss per share from continuing operations was NOK 1.01 compared to NOK 1.12 a year ago.